EGFR and breast cancer: This may be due to higher lipid raft PL incorporation of DHA [17], a greater decrease in cell viability [12,25,29,31,33], higher apoptosis [12,24], and lower levels of pEGFR [24] and EGFR [25] in tumour cells with DHA treatment compared to MDA-MB-231 BC cells treated with EPA.